Session-aware quotes · provider delays vary · Not financial advice
NeutralMEDIUM severityEarnings26d ago

Boston Scientific expects 2026 organic revenue growth of 5%-6% and outlines $500M run-rate savings exiting 2029

Reported by Seeking Alpha · seekingalpha.com · July 29, 2026

$BSX
Neutral read

Boston Scientific (BSX) Q2 2026 earnings call: Q2 results, lowered 2026 guidance, WATCHMAN/EP pressures, and $500M restructuring plan.

What the tape says

What to watch: Boston Scientific Corp. (BSX) cut guidance by 5% — a cut like this often precedes further estimate revisions across the sector.

Amount
$500 million
Change
5%
Change
-6%

Market reaction today: $BSX -2.70%

Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Seeking Alpha's reporting.

Your read

Discussion

No one has weighed in yet. Start the discussion on this story.

More coverage on these names

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.